NanoKnife
What is IRE Technology?
What is IRE Technology?
The NanoKnife System harnesses the power of Irreversible Electroporation (IRE) to effectively destroy target cells without the use of thermal energy.
PRESERVE Study
PRESERVE Study
PRESERVE is a clinical study, initiated by AngioDynamics, Inc. in partnership with the Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), evaluating the use of the NanoKnife System as a focal therapy option for prostate cancer patients. It will assess the safety and effectiveness of the device when used to ablate prostate tissue in intermediate risk prostate cancer patients.
Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
PRESERVE is a US-based study and is currently enrolling active hospital sites and qualifying patients.
To find out more, email Dr Barqawi directly Al.Barqawi@ucdenver.edu